Avion Health vs CoverMyMeds
Side-by-side comparison of AI visibility scores, market position, and capabilities
US YC W20 medical drone delivery of pharma/blood/diagnostics to remote clinics; $4.73M seed 2024-2025 with eVTOL drones and autonomous routing competing with Zipline for rural healthcare supply chain access.
About
Avion Health is a United States-based drone-based medical supply delivery platform — backed by Y Combinator (W20) with $4.73 million in seed funding in 2024-2025 — providing healthcare facilities and communities with autonomous eVTOL (electric vertical take-off and landing) drone delivery of vital medical supplies including pharmaceuticals, blood products, and diagnostic samples, bridging the accessibility gap between remote clinics and urban healthcare infrastructure. Operating pilot programs across the United States and internationally, Avion's drones feature GPS tracking, autonomous route correction, and real-time diagnostics — delivering to hard-to-reach areas with significant time savings compared to ground transportation and enabling same-hour medical supply access in geographies where traditional logistics are too slow for clinical urgency. Founded in 2019.
Largest prior authorization network in the US connecting 75K+ pharmacies, 750K+ providers, and all payers. Columbus OH; acquired by McKesson; available free to providers and pharmacies; processes millions of PA requests annually for specialty and retail prescriptions at no provider cost.
About
CoverMyMeds is the largest prior authorization platform in the United States, operating a network that connects more than 750,000 providers, 75,000 pharmacies, and virtually all payers to streamline the authorization process for prescription medications. Founded in 2008 in Columbus, Ohio, and acquired by McKesson Corporation in 2017, CoverMyMeds processes millions of prior authorization requests annually and has become foundational infrastructure for the US pharmacy and specialty medication market. The platform is available at no cost to providers and pharmacies and is funded through health plan and PBM partnerships.\n\nCoverMyMeds' network effect is central to its value: because the platform is used by the vast majority of pharmacies and a very large share of prescribing providers, payers can reach their entire provider and pharmacy network through a single connection. The platform supports real-time benefit checks that show the formulary status and prior authorization requirements for a drug at the point of prescribing, enabling providers to make more informed prescribing decisions before a patient reaches the pharmacy counter. Automated electronic prior authorization (ePA) workflows reduce approval times from days to hours for eligible drug-payer combinations.\n\nAs part of McKesson, CoverMyMeds has expanded its capabilities to include specialty medication access solutions, patient assistance program enrollment, and medication adherence tools. The company's RxCrossroads subsidiary provides hub services for specialty pharmaceutical manufacturers, creating a comprehensive access ecosystem that spans from initial authorization through patient support and adherence management.
AI Visibility Head-to-Head
Key Details
Capabilities & Ecosystem
Capabilities
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.